SAN DIEGO—A combination of multimodal medications and medically supervised weight loss is significantly more effective in encouraging preoperative weight loss in extremely obese patients than either glucagon-like peptide-1 (GLP-1) monotherapy or medically supervised weight loss alone, according to a new study. The results were presented at the 2024 annual meeting of the American Society for Metabolic and Bariatric Surgery.
Investigators at Louisiana State